ClearPoint-13169-Final-Logo-CMYK jpg.jpg
Importance of Real-Time MRI Guidance in Delivery of Toca 511 Gene Therapy Directly to High Grade Glioma Presented at Annual Society for Neuro-Oncology Scientific Meeting
December 03, 2013 08:00 ET | ClearPoint Neuro, Inc.
IRVINE, Calif., Dec. 3, 2013 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced the presentation of clinical data demonstrating the precision of MRI-guided delivery of the...
Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Convoy Therapeutics, Inc.
June 19, 2013 08:30 ET | Crystal Research Associates, LLC
NEW YORK, NY--(Marketwired - Jun 19, 2013) - Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO) on Convoy Therapeutics, Inc. The...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
MRI Interventions' ClearPoint(R) System Helps Advance Brain Cancer Clinical Trial of Investigational Gene Therapy Drug Toca 511, Demonstrates Benefits of MRI-Guided Drug Delivery
April 25, 2013 08:00 ET | ClearPoint Neuro, Inc.
IRVINE, Calif., April 25, 2013 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint® Neuro Intervention System is advancing the minimally-invasive...
TissueGen Announces ELUTE(TM) Biodegradable Drug-Loaded Fiber
April 09, 2013 10:00 ET | TissueGen Inc
DALLAS, TX--(Marketwired - Apr 9, 2013) - TissueGen® Inc., developer of cutting-edge biodegradable polymer technology for implantable drug delivery across a wide variety of therapeutic...
TissueGen and Biomedical Structures Announce Availability of Breakthrough Drug Delivery Platform for Implantable Devices
February 12, 2013 10:00 ET | TissueGen Inc.
DALLAS, TX and WARWICK, RI--(Marketwire - Feb 12, 2013) -   TissueGen® Inc., developer of a cutting-edge absorbable polymer technology for implantable drug delivery across a wide...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Announces First Shipment of Generic Phendimetrazine Tablet Product
November 15, 2012 07:00 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Nov. 15, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today the initial shipment of Phendimetrazine tartrate 35 mg tablets, the generic...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Announces Fiscal Year 2013 Second Quarter Investor Conference Call on Thursday, November 15, 2012
November 13, 2012 13:34 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Nov. 13, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...
InvisiDerm Healthcare Logo
InvisiDerm Healthcare Completes Successful Clinical Trial of Transdermal Delivery, Discusses Medical Applications
November 12, 2012 09:17 ET | InvisiDerm Healthcare
PASADENA, Calif., Nov. 12, 2012 (GLOBE NEWSWIRE) -- InvisiDerm Healthcare ("InvisiDerm"), developer and manufacturer of noninvasive gas and drug delivery methods, announced the completion of the...
UMD, Inc. Announces Patent Application Filing for pH Modulated Films for Delivery of Actives
October 13, 2008 12:05 ET | UMD, Inc.
CINCINNATI, OH--(Marketwire - October 13, 2008) - UMD, Inc., a Cincinnati drug delivery company, today announced the filing of U.S. Patent Application Serial No. 12/130,279. The application deals...
Situs Corp. Announces Appointment Of Two New Members To Scientific Advisory Board
December 01, 1999 08:17 ET | Situs Corporation
SOLANA BEACH, Calif., Dec. 1, 1999 (PRIMEZONE) -- Situs Corp. (www.situscorp.com), a pioneer in intravesical drug delivery, today announced the appointments of Alan Hugh Bennett, M.D. and Randall...